APA
Petersen L. K., Restrepo J., Moreira E. D., Iversen O., Pitisuttithum P., Van Damme P., Joura E. A., Olsson S., Ferris D., Block S., Giuliano A. R., Bosch X., Pils S., Cuzick J., Garland S. M., Huh W., Kjaer S. K., Bautista O. M., Hyatt D., Maansson R., Moeller E., Qi H., Roberts C. & Luxembourg A. (2017). Impact of baseline covariates on the immunogenicity of the 9-valent HPV vaccine - A combined analysis of five phase III clinical trials. : Papillomavirus research (Amsterdam, Netherlands).
Chicago
Petersen Lone K, Restrepo Jaime, Moreira Edson D, Iversen Ole-Erik, Pitisuttithum Punnee, Van Damme Pierre, Joura Elmar A, Olsson Sven-Erik, Ferris Daron, Block Stan, Giuliano Anna R, Bosch Xavier, Pils Sophie, Cuzick Jack, Garland Suzanne M, Huh Warner, Kjaer Susanne K, Bautista Oliver M, Hyatt Donna, Maansson Roger, Moeller Erin, Qi Hong, Roberts Christine and Luxembourg Alain. 2017. Impact of baseline covariates on the immunogenicity of the 9-valent HPV vaccine - A combined analysis of five phase III clinical trials. : Papillomavirus research (Amsterdam, Netherlands).
Harvard
Petersen L. K., Restrepo J., Moreira E. D., Iversen O., Pitisuttithum P., Van Damme P., Joura E. A., Olsson S., Ferris D., Block S., Giuliano A. R., Bosch X., Pils S., Cuzick J., Garland S. M., Huh W., Kjaer S. K., Bautista O. M., Hyatt D., Maansson R., Moeller E., Qi H., Roberts C. and Luxembourg A. (2017). Impact of baseline covariates on the immunogenicity of the 9-valent HPV vaccine - A combined analysis of five phase III clinical trials. : Papillomavirus research (Amsterdam, Netherlands).
MLA
Petersen Lone K, Restrepo Jaime, Moreira Edson D, Iversen Ole-Erik, Pitisuttithum Punnee, Van Damme Pierre, Joura Elmar A, Olsson Sven-Erik, Ferris Daron, Block Stan, Giuliano Anna R, Bosch Xavier, Pils Sophie, Cuzick Jack, Garland Suzanne M, Huh Warner, Kjaer Susanne K, Bautista Oliver M, Hyatt Donna, Maansson Roger, Moeller Erin, Qi Hong, Roberts Christine and Luxembourg Alain. Impact of baseline covariates on the immunogenicity of the 9-valent HPV vaccine - A combined analysis of five phase III clinical trials. : Papillomavirus research (Amsterdam, Netherlands). 2017.